サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1390345

世界のG-CSF注射市場：考察と予測 (2029年まで)

Global G-CSF Injection Market Insights, Forecast to 2029
出版日: | 発行: QYResearch | ページ情報: 英文 109 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界のG-CSF注射市場：考察と予測 (2029年まで)
出版日: 2023年12月06日
発行: QYResearch
ページ情報: 英文 109 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、G-CSF注射 (G-CSF Injection) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • G-CSF注射の製品概要
  • 市場：タイプ別
    • 世界のG-CSF注射の市場規模成長率：タイプ別, 2018 VS 2022 VS 2029
    • Long-acting G-CSF Injection
    • Short-acting G-CSF Injection
  • 市場：用途別
    • 世界のG-CSF注射の市場規模成長率：用途別, 2018 VS 2022 VS 2029
    • Neoplastic Diseases
    • Blood Disorders
    • Others
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界のG-CSF注射売上予測・予想 2018-2029
  • 世界のG-CSF注射の収益：地域別
    • 世界のG-CSF注射の収益：地域別: 2018 VS 2022 VS 2029
    • 世界のG-CSF注射の収益：地域別 (2018-2023)
    • 世界のG-CSF注射の収益：地域別 (2024-2029)
    • 世界のG-CSF注射の収益市場シェア 地域別 (2018-2029)
  • 世界のG-CSF注射売上予測・予想 2018-2029
  • 世界のG-CSF注射の販売：地域別
    • 世界のG-CSF注射の販売：地域別: 2018 VS 2022 VS 2029
    • 世界のG-CSF注射の販売：地域別 (2018-2023)
    • 世界のG-CSF注射の販売：地域別 (2024-2029)
    • 世界のG-CSF注射の販売市場シェア 地域別 (2018-2029)
  • 米国・カナダ
  • 欧州
  • 中国
  • アジア（中国を除く）
  • 中東, アフリカ ・ラテンアメリカ

第3章 競合：企業別

  • 世界のG-CSF注射の販売：企業別
    • 世界のG-CSF注射の販売：企業別 (2018-2023)
    • 世界のG-CSF注射の販売市場シェア：企業別 (2018-2023)
    • 世界の上位10・上位5企業： G-CSF注射 in 2022
  • 世界のG-CSF注射の収益：企業別
    • 世界のG-CSF注射の収益：企業別 (2018-2023)
    • 世界のG-CSF注射の収益市場シェア：企業別 (2018-2023)
    • 世界の上位10・上位5企業： G-CSF注射の収益 2022
  • 世界の主要企業 G-CSF注射, 業界ランキング, 2021 VS 2022 VS 2023
  • 世界のG-CSF注射の販売価格：企業別
  • 競合情勢の分析
    • 企業の市場集中度 (CR5 and HHI)
    • 世界のG-CSF注射の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要メーカー G-CSF注射, 製造拠点分布と本社
  • 世界の主要メーカー G-CSF注射, 提供製品と用途
  • 世界の主要メーカー G-CSF注射, 業界参入時期
  • M&A, 拡張計画

第4章 市場規模：タイプ別

  • 世界のG-CSF注射の販売：タイプ別
    • 世界のG-CSF注射の販売実績：タイプ別 (2018-2023)
    • 世界のG-CSF注射の販売予測：タイプ別 (2024-2029)
    • 世界のG-CSF注射の販売市場シェア：タイプ別 (2018-2029)
  • 世界のG-CSF注射 収益：タイプ別
    • 世界のG-CSF注射の収益実績：タイプ別 (2018-2023)
    • 世界のG-CSF注射の収益予測：タイプ別 (2024-2029)
    • 世界のG-CSF注射の収益市場シェア：タイプ別 (2018-2029)
  • 世界のG-CSF注射の価格：タイプ別
    • 世界のG-CSF注射の価格：タイプ別 (2018-2023)
    • 世界のG-CSF注射の価格予測：タイプ別 (2024-2029)

第5章 市場規模：用途別

  • 世界のG-CSF注射の販売：用途別
    • 世界のG-CSF注射の販売実績：用途別 (2018-2023)
    • 世界のG-CSF注射の販売予測：用途別 (2024-2029)
    • 世界のG-CSF注射の販売市場シェア：用途別 (2018-2029)
  • 世界のG-CSF注射の収益：用途別
    • 世界のG-CSF注射の収益実績：用途別 (2018-2023)
    • 世界のG-CSF注射の収益予測：用途別 (2024-2029)
    • 世界のG-CSF注射の収益市場シェア：用途別 (2018-2029)
  • 世界のG-CSF注射の価格：用途別
    • 世界のG-CSF注射の価格：用途別 (2018-2023)
    • 世界のG-CSF注射の価格予測：用途別 (2024-2029)

第6章 米国・カナダ

  • 米国・カナダ G-CSF注射 市場規模：タイプ別
    • 米国・カナダ G-CSF注射の販売：タイプ別 (2018-2029)
    • 米国・カナダ G-CSF注射 収益：タイプ別 (2018-2029)
  • 米国・カナダ G-CSF注射 市場規模：用途別
    • 米国・カナダ G-CSF注射の販売：用途別 (2018-2029)
    • 米国・カナダ G-CSF注射の収益：用途別 (2018-2029)
  • 米国・カナダ G-CSF注射 市場規模：国別
    • 米国・カナダ G-CSF注射の収益：国別: 2018 VS 2022 VS 2029
    • 米国・カナダ G-CSF注射の販売：国別 (2018-2029)
    • 米国・カナダ G-CSF注射の収益：国別 (2018-2029)
    • US
    • カナダ

第7章 欧州

  • 欧州のG-CSF注射 市場規模：タイプ別
    • 欧州のG-CSF注射の販売：タイプ別 (2018-2029)
    • 欧州のG-CSF注射 収益：タイプ別 (2018-2029)
  • 欧州のG-CSF注射 市場規模：用途別
    • 欧州のG-CSF注射の販売：用途別 (2018-2029)
    • 欧州のG-CSF注射の収益：用途別 (2018-2029)
  • 欧州のG-CSF注射 市場規模：国別
    • 欧州のG-CSF注射の収益：国別: 2018 VS 2022 VS 2029
    • 欧州のG-CSF注射の販売：国別 (2018-2029)
    • 欧州のG-CSF注射の収益：国別 (2018-2029)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 中国

  • 中国のG-CSF注射 市場規模
    • 中国のG-CSF注射 売上 (2018-2029)
    • 中国のG-CSF注射 収益 (2018-2029)
  • 中国のG-CSF注射 市場規模：用途別
    • 中国のG-CSF注射の販売：用途別 (2018-2029)
    • 中国のG-CSF注射の収益：用途別 (2018-2029)

第9章 アジア（中国を除く）

  • アジア地域 G-CSF注射 市場規模：タイプ別
    • アジア地域 G-CSF注射の販売：タイプ別 (2018-2029)
    • アジア地域 G-CSF注射 収益：タイプ別 (2018-2029)
  • アジア地域 G-CSF注射 市場規模：用途別
    • アジア地域 G-CSF注射の販売：用途別 (2018-2029)
    • アジア地域 G-CSF注射の収益：用途別 (2018-2029)
  • アジア地域 G-CSF注射の販売：地域別
    • アジア地域 G-CSF注射の収益：地域別: 2018 VS 2022 VS 2029
    • アジア地域 G-CSF注射の収益：地域別 (2018-2029)
    • アジア地域 G-CSF注射の販売：地域別 (2018-2029)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド

第10章 中東, アフリカ ・ラテンアメリカ

  • 中東, アフリカ ・ラテンアメリカのG-CSF注射 市場規模：タイプ別
    • 中東, アフリカ ・ラテンアメリカのG-CSF注射の販売：タイプ別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカのG-CSF注射 収益：タイプ別 (2018-2029)
  • 中東, アフリカ ・ラテンアメリカのG-CSF注射 市場規模：用途別
    • 中東, アフリカ ・ラテンアメリカのG-CSF注射の販売：用途別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカのG-CSF注射の収益：用途別 (2018-2029)
  • 中東, アフリカ ・ラテンアメリカのG-CSF注射の販売：国別
    • 中東, アフリカ ・ラテンアメリカのG-CSF注射の収益：国別: 2018 VS 2022 VS 2029
    • 中東, アフリカ ・ラテンアメリカのG-CSF注射の収益：国別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカのG-CSF注射の販売：国別 (2018-2029)
    • ブラジル
    • メキシコ
    • トルコ
    • イスラエル
    • 湾岸協力理事会諸国

第11章 企業プロファイル

  • Amgen Inc.
  • Pfizer
  • Sandoz (Novartis)
  • Spectrum Pharmaceuticals
  • Biocon Biologics Inc.
  • Coherus BioSciences, Inc.
  • Teva Pharmaceutical
  • Sanofi
  • Yifan Pharmaceutical
  • CSPC
  • Jiangsu Hengrui Medicine
  • Qilu Pharmaceutical
  • Shan Dong Kexing Biopharm

第12章 業界チェーンと販売チャネルの分析

  • G-CSF注射 業界チェーン分析
  • G-CSF注射 主要原材料
    • 主要原材料
    • 原材料の主要サプライヤー
  • G-CSF注射 生産形態とプロセス
  • G-CSF注射 販売およびマーケティング
    • G-CSF注射 販売チャネルs
    • G-CSF注射 卸業者
  • G-CSF注射 顧客

第13章 市場動向

  • G-CSF注射 業界動向
  • G-CSF注射 市場の促進要因
  • G-CSF注射 市場の課題
  • G-CSF注射 市場の抑制要因

第14章 主な調査結果 世界のG-CSF注射の主な市場調査結果

第15章 付録

図表

List of Tables

  • Table 1. Global G-CSF Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 2. Major Manufacturers of Long-acting G-CSF Injection
  • Table 3. Major Manufacturers of Short-acting G-CSF Injection
  • Table 4. Global G-CSF Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 5. Global G-CSF Injection Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 6. Global G-CSF Injection Revenue by Region (2018-2023) & (US$ Million)
  • Table 7. Global G-CSF Injection Revenue by Region (2024-2029) & (US$ Million)
  • Table 8. Global G-CSF Injection Revenue Market Share by Region (2018-2023)
  • Table 9. Global G-CSF Injection Revenue Market Share by Region (2024-2029)
  • Table 10. Global G-CSF Injection Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 11. Global G-CSF Injection Sales by Region (2018-2023) & (K Units)
  • Table 12. Global G-CSF Injection Sales by Region (2024-2029) & (K Units)
  • Table 13. Global G-CSF Injection Sales Market Share by Region (2018-2023)
  • Table 14. Global G-CSF Injection Sales Market Share by Region (2024-2029)
  • Table 15. Global G-CSF Injection Sales by Manufacturers (2018-2023) & (K Units)
  • Table 16. Global G-CSF Injection Sales Share by Manufacturers (2018-2023)
  • Table 17. Global G-CSF Injection Revenue by Manufacturers (2018-2023) & (US$ Million)
  • Table 18. Global G-CSF Injection Revenue Share by Manufacturers (2018-2023)
  • Table 19. Global Key Players of G-CSF Injection, Industry Ranking, 2021 VS 2022 VS 2023
  • Table 20. G-CSF Injection Price by Manufacturers 2018-2023 (US$/Unit)
  • Table 21. Global G-CSF Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 22. Global G-CSF Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in G-CSF Injection as of 2022)
  • Table 23. Global Key Manufacturers of G-CSF Injection, Manufacturing Base Distribution and Headquarters
  • Table 24. Global Key Manufacturers of G-CSF Injection, Product Offered and Application
  • Table 25. Global Key Manufacturers of G-CSF Injection, Date of Enter into This Industry
  • Table 26. Mergers & Acquisitions, Expansion Plans
  • Table 27. Global G-CSF Injection Sales by Type (2018-2023) & (K Units)
  • Table 28. Global G-CSF Injection Sales by Type (2024-2029) & (K Units)
  • Table 29. Global G-CSF Injection Sales Share by Type (2018-2023)
  • Table 30. Global G-CSF Injection Sales Share by Type (2024-2029)
  • Table 31. Global G-CSF Injection Revenue by Type (2018-2023) & (US$ Million)
  • Table 32. Global G-CSF Injection Revenue by Type (2024-2029) & (US$ Million)
  • Table 33. Global G-CSF Injection Revenue Share by Type (2018-2023)
  • Table 34. Global G-CSF Injection Revenue Share by Type (2024-2029)
  • Table 35. G-CSF Injection Price by Type (2018-2023) & (US$/Unit)
  • Table 36. Global G-CSF Injection Price Forecast by Type (2024-2029) & (US$/Unit)
  • Table 37. Global G-CSF Injection Sales by Application (2018-2023) & (K Units)
  • Table 38. Global G-CSF Injection Sales by Application (2024-2029) & (K Units)
  • Table 39. Global G-CSF Injection Sales Share by Application (2018-2023)
  • Table 40. Global G-CSF Injection Sales Share by Application (2024-2029)
  • Table 41. Global G-CSF Injection Revenue by Application (2018-2023) & (US$ Million)
  • Table 42. Global G-CSF Injection Revenue by Application (2024-2029) & (US$ Million)
  • Table 43. Global G-CSF Injection Revenue Share by Application (2018-2023)
  • Table 44. Global G-CSF Injection Revenue Share by Application (2024-2029)
  • Table 45. G-CSF Injection Price by Application (2018-2023) & (US$/Unit)
  • Table 46. Global G-CSF Injection Price Forecast by Application (2024-2029) & (US$/Unit)
  • Table 47. US & Canada G-CSF Injection Sales by Type (2018-2023) & (K Units)
  • Table 48. US & Canada G-CSF Injection Sales by Type (2024-2029) & (K Units)
  • Table 49. US & Canada G-CSF Injection Revenue by Type (2018-2023) & (US$ Million)
  • Table 50. US & Canada G-CSF Injection Revenue by Type (2024-2029) & (US$ Million)
  • Table 51. US & Canada G-CSF Injection Sales by Application (2018-2023) & (K Units)
  • Table 52. US & Canada G-CSF Injection Sales by Application (2024-2029) & (K Units)
  • Table 53. US & Canada G-CSF Injection Revenue by Application (2018-2023) & (US$ Million)
  • Table 54. US & Canada G-CSF Injection Revenue by Application (2024-2029) & (US$ Million)
  • Table 55. US & Canada G-CSF Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 56. US & Canada G-CSF Injection Revenue by Country (2018-2023) & (US$ Million)
  • Table 57. US & Canada G-CSF Injection Revenue by Country (2024-2029) & (US$ Million)
  • Table 58. US & Canada G-CSF Injection Sales by Country (2018-2023) & (K Units)
  • Table 59. US & Canada G-CSF Injection Sales by Country (2024-2029) & (K Units)
  • Table 60. Europe G-CSF Injection Sales by Type (2018-2023) & (K Units)
  • Table 61. Europe G-CSF Injection Sales by Type (2024-2029) & (K Units)
  • Table 62. Europe G-CSF Injection Revenue by Type (2018-2023) & (US$ Million)
  • Table 63. Europe G-CSF Injection Revenue by Type (2024-2029) & (US$ Million)
  • Table 64. Europe G-CSF Injection Sales by Application (2018-2023) & (K Units)
  • Table 65. Europe G-CSF Injection Sales by Application (2024-2029) & (K Units)
  • Table 66. Europe G-CSF Injection Revenue by Application (2018-2023) & (US$ Million)
  • Table 67. Europe G-CSF Injection Revenue by Application (2024-2029) & (US$ Million)
  • Table 68. Europe G-CSF Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 69. Europe G-CSF Injection Revenue by Country (2018-2023) & (US$ Million)
  • Table 70. Europe G-CSF Injection Revenue by Country (2024-2029) & (US$ Million)
  • Table 71. Europe G-CSF Injection Sales by Country (2018-2023) & (K Units)
  • Table 72. Europe G-CSF Injection Sales by Country (2024-2029) & (K Units)
  • Table 73. China G-CSF Injection Sales by Type (2018-2023) & (K Units)
  • Table 74. China G-CSF Injection Sales by Type (2024-2029) & (K Units)
  • Table 75. China G-CSF Injection Revenue by Type (2018-2023) & (US$ Million)
  • Table 76. China G-CSF Injection Revenue by Type (2024-2029) & (US$ Million)
  • Table 77. China G-CSF Injection Sales by Application (2018-2023) & (K Units)
  • Table 78. China G-CSF Injection Sales by Application (2024-2029) & (K Units)
  • Table 79. China G-CSF Injection Revenue by Application (2018-2023) & (US$ Million)
  • Table 80. China G-CSF Injection Revenue by Application (2024-2029) & (US$ Million)
  • Table 81. Asia G-CSF Injection Sales by Type (2018-2023) & (K Units)
  • Table 82. Asia G-CSF Injection Sales by Type (2024-2029) & (K Units)
  • Table 83. Asia G-CSF Injection Revenue by Type (2018-2023) & (US$ Million)
  • Table 84. Asia G-CSF Injection Revenue by Type (2024-2029) & (US$ Million)
  • Table 85. Asia G-CSF Injection Sales by Application (2018-2023) & (K Units)
  • Table 86. Asia G-CSF Injection Sales by Application (2024-2029) & (K Units)
  • Table 87. Asia G-CSF Injection Revenue by Application (2018-2023) & (US$ Million)
  • Table 88. Asia G-CSF Injection Revenue by Application (2024-2029) & (US$ Million)
  • Table 89. Asia G-CSF Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 90. Asia G-CSF Injection Revenue by Region (2018-2023) & (US$ Million)
  • Table 91. Asia G-CSF Injection Revenue by Region (2024-2029) & (US$ Million)
  • Table 92. Asia G-CSF Injection Sales by Region (2018-2023) & (K Units)
  • Table 93. Asia G-CSF Injection Sales by Region (2024-2029) & (K Units)
  • Table 94. Middle East, Africa and Latin America G-CSF Injection Sales by Type (2018-2023) & (K Units)
  • Table 95. Middle East, Africa and Latin America G-CSF Injection Sales by Type (2024-2029) & (K Units)
  • Table 96. Middle East, Africa and Latin America G-CSF Injection Revenue by Type (2018-2023) & (US$ Million)
  • Table 97. Middle East, Africa and Latin America G-CSF Injection Revenue by Type (2024-2029) & (US$ Million)
  • Table 98. Middle East, Africa and Latin America G-CSF Injection Sales by Application (2018-2023) & (K Units)
  • Table 99. Middle East, Africa and Latin America G-CSF Injection Sales by Application (2024-2029) & (K Units)
  • Table 100. Middle East, Africa and Latin America G-CSF Injection Revenue by Application (2018-2023) & (US$ Million)
  • Table 101. Middle East, Africa and Latin America G-CSF Injection Revenue by Application (2024-2029) & (US$ Million)
  • Table 102. Middle East, Africa and Latin America G-CSF Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 103. Middle East, Africa and Latin America G-CSF Injection Revenue by Country (2018-2023) & (US$ Million)
  • Table 104. Middle East, Africa and Latin America G-CSF Injection Revenue by Country (2024-2029) & (US$ Million)
  • Table 105. Middle East, Africa and Latin America G-CSF Injection Sales by Country (2018-2023) & (K Units)
  • Table 106. Middle East, Africa and Latin America G-CSF Injection Sales by Country (2024-2029) & (K Units)
  • Table 107. Amgen Inc. Company Information
  • Table 108. Amgen Inc. Description and Major Businesses
  • Table 109. Amgen Inc. G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 110. Amgen Inc. G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 111. Amgen Inc. Recent Developments
  • Table 112. Pfizer Company Information
  • Table 113. Pfizer Description and Major Businesses
  • Table 114. Pfizer G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 115. Pfizer G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 116. Pfizer Recent Developments
  • Table 117. Sandoz (Novartis) Company Information
  • Table 118. Sandoz (Novartis) Description and Major Businesses
  • Table 119. Sandoz (Novartis) G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 120. Sandoz (Novartis) G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 121. Sandoz (Novartis) Recent Developments
  • Table 122. Spectrum Pharmaceuticals Company Information
  • Table 123. Spectrum Pharmaceuticals Description and Major Businesses
  • Table 124. Spectrum Pharmaceuticals G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 125. Spectrum Pharmaceuticals G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 126. Spectrum Pharmaceuticals Recent Developments
  • Table 127. Biocon Biologics Inc. Company Information
  • Table 128. Biocon Biologics Inc. Description and Major Businesses
  • Table 129. Biocon Biologics Inc. G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 130. Biocon Biologics Inc. G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 131. Biocon Biologics Inc. Recent Developments
  • Table 132. Coherus BioSciences, Inc. Company Information
  • Table 133. Coherus BioSciences, Inc. Description and Major Businesses
  • Table 134. Coherus BioSciences, Inc. G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 135. Coherus BioSciences, Inc. G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 136. Coherus BioSciences, Inc. Recent Developments
  • Table 137. Teva Pharmaceutical Company Information
  • Table 138. Teva Pharmaceutical Description and Major Businesses
  • Table 139. Teva Pharmaceutical G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 140. Teva Pharmaceutical G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 141. Teva Pharmaceutical Recent Developments
  • Table 142. Sanofi Company Information
  • Table 143. Sanofi Description and Major Businesses
  • Table 144. Sanofi G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 145. Sanofi G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 146. Sanofi Recent Developments
  • Table 147. Yifan Pharmaceutical Company Information
  • Table 148. Yifan Pharmaceutical Description and Major Businesses
  • Table 149. Yifan Pharmaceutical G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 150. Yifan Pharmaceutical G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 151. Yifan Pharmaceutical Recent Developments
  • Table 152. CSPC Company Information
  • Table 153. CSPC Description and Major Businesses
  • Table 154. CSPC G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 155. CSPC G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 156. CSPC Recent Developments
  • Table 157. Jiangsu Hengrui Medicine Company Information
  • Table 158. Jiangsu Hengrui Medicine Description and Major Businesses
  • Table 159. Jiangsu Hengrui Medicine G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 160. Jiangsu Hengrui Medicine G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 161. Jiangsu Hengrui Medicine Recent Developments
  • Table 162. Qilu Pharmaceutical Company Information
  • Table 163. Qilu Pharmaceutical Description and Major Businesses
  • Table 164. Qilu Pharmaceutical G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 165. Qilu Pharmaceutical G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 166. Qilu Pharmaceutical Recent Developments
  • Table 167. Shan Dong Kexing Biopharm Company Information
  • Table 168. Shan Dong Kexing Biopharm Description and Major Businesses
  • Table 169. Shan Dong Kexing Biopharm G-CSF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 170. Shan Dong Kexing Biopharm G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 171. Shan Dong Kexing Biopharm Recent Developments
  • Table 172. Key Raw Materials Lists
  • Table 173. Raw Materials Key Suppliers Lists
  • Table 174. G-CSF Injection Distributors List
  • Table 175. G-CSF Injection Customers List
  • Table 176. G-CSF Injection Market Trends
  • Table 177. G-CSF Injection Market Drivers
  • Table 178. G-CSF Injection Market Challenges
  • Table 179. G-CSF Injection Market Restraints
  • Table 180. Research Programs/Design for This Report
  • Table 181. Key Data Information from Secondary Sources
  • Table 182. Key Data Information from Primary Sources

List of Figures

  • Figure 1. G-CSF Injection Product Picture
  • Figure 2. Global G-CSF Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 3. Global G-CSF Injection Market Share by Type in 2022 & 2029
  • Figure 4. Long-acting G-CSF Injection Product Picture
  • Figure 5. Short-acting G-CSF Injection Product Picture
  • Figure 6. Global G-CSF Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 7. Global G-CSF Injection Market Share by Application in 2022 & 2029
  • Figure 8. Neoplastic Diseases
  • Figure 9. Blood Disorders
  • Figure 10. Others
  • Figure 11. G-CSF Injection Report Years Considered
  • Figure 12. Global G-CSF Injection Revenue, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 13. Global G-CSF Injection Revenue 2018-2029 (US$ Million)
  • Figure 14. Global G-CSF Injection Revenue Market Share by Region in Percentage: 2022 Versus 2029
  • Figure 15. Global G-CSF Injection Revenue Market Share by Region (2018-2029)
  • Figure 16. Global G-CSF Injection Sales 2018-2029 ((K Units)
  • Figure 17. Global G-CSF Injection Sales Market Share by Region (2018-2029)
  • Figure 18. US & Canada G-CSF Injection Sales YoY (2018-2029) & (K Units)
  • Figure 19. US & Canada G-CSF Injection Revenue YoY (2018-2029) & (US$ Million)
  • Figure 20. Europe G-CSF Injection Sales YoY (2018-2029) & (K Units)
  • Figure 21. Europe G-CSF Injection Revenue YoY (2018-2029) & (US$ Million)
  • Figure 22. China G-CSF Injection Sales YoY (2018-2029) & (K Units)
  • Figure 23. China G-CSF Injection Revenue YoY (2018-2029) & (US$ Million)
  • Figure 24. Asia (excluding China) G-CSF Injection Sales YoY (2018-2029) & (K Units)
  • Figure 25. Asia (excluding China) G-CSF Injection Revenue YoY (2018-2029) & (US$ Million)
  • Figure 26. Middle East, Africa and Latin America G-CSF Injection Sales YoY (2018-2029) & (K Units)
  • Figure 27. Middle East, Africa and Latin America G-CSF Injection Revenue YoY (2018-2029) & (US$ Million)
  • Figure 28. The G-CSF Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
  • Figure 29. The Top 5 and 10 Largest Manufacturers of G-CSF Injection in the World: Market Share by G-CSF Injection Revenue in 2022
  • Figure 30. Global G-CSF Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
  • Figure 31. Global G-CSF Injection Sales Market Share by Type (2018-2029)
  • Figure 32. Global G-CSF Injection Revenue Market Share by Type (2018-2029)
  • Figure 33. Global G-CSF Injection Sales Market Share by Application (2018-2029)
  • Figure 34. Global G-CSF Injection Revenue Market Share by Application (2018-2029)
  • Figure 35. US & Canada G-CSF Injection Sales Market Share by Type (2018-2029)
  • Figure 36. US & Canada G-CSF Injection Revenue Market Share by Type (2018-2029)
  • Figure 37. US & Canada G-CSF Injection Sales Market Share by Application (2018-2029)
  • Figure 38. US & Canada G-CSF Injection Revenue Market Share by Application (2018-2029)
  • Figure 39. US & Canada G-CSF Injection Revenue Share by Country (2018-2029)
  • Figure 40. US & Canada G-CSF Injection Sales Share by Country (2018-2029)
  • Figure 41. U.S. G-CSF Injection Revenue (2018-2029) & (US$ Million)
  • Figure 42. Canada G-CSF Injection Revenue (2018-2029) & (US$ Million)
  • Figure 43. Europe G-CSF Injection Sales Market Share by Type (2018-2029)
  • Figure 44. Europe G-CSF Injection Revenue Market Share by Type (2018-2029)
  • Figure 45. Europe G-CSF Injection Sales Market Share by Application (2018-2029)
  • Figure 46. Europe G-CSF Injection Revenue Market Share by Application (2018-2029)
  • Figure 47. Europe G-CSF Injection Revenue Share by Country (2018-2029)
  • Figure 48. Europe G-CSF Injection Sales Share by Country (2018-2029)
  • Figure 49. Germany G-CSF Injection Revenue (2018-2029) & (US$ Million)
  • Figure 50. France G-CSF Injection Revenue (2018-2029) & (US$ Million)
  • Figure 51. U.K. G-CSF Injection Revenue (2018-2029) & (US$ Million)
  • Figure 52. Italy G-CSF Injection Revenue (2018-2029) & (US$ Million)
  • Figure 53. Russia G-CSF Injection Revenue (2018-2029) & (US$ Million)
  • Figure 54. China G-CSF Injection Sales Market Share by Type (2018-2029)
  • Figure 55. China G-CSF Injection Revenue Market Share by Type (2018-2029)
  • Figure 56. China G-CSF Injection Sales Market Share by Application (2018-2029)
  • Figure 57. China G-CSF Injection Revenue Market Share by Application (2018-2029)
  • Figure 58. Asia G-CSF Injection Sales Market Share by Type (2018-2029)
  • Figure 59. Asia G-CSF Injection Revenue Market Share by Type (2018-2029)
  • Figure 60. Asia G-CSF Injection Sales Market Share by Application (2018-2029)
  • Figure 61. Asia G-CSF Injection Revenue Market Share by Application (2018-2029)
  • Figure 62. Asia G-CSF Injection Revenue Share by Region (2018-2029)
  • Figure 63. Asia G-CSF Injection Sales Share by Region (2018-2029)
  • Figure 64. Japan G-CSF Injection Revenue (2018-2029) & (US$ Million)
  • Figure 65. South Korea G-CSF Injection Revenue (2018-2029) & (US$ Million)
  • Figure 66. China Taiwan G-CSF Injection Revenue (2018-2029) & (US$ Million)
  • Figure 67. Southeast Asia G-CSF Injection Revenue (2018-2029) & (US$ Million)
  • Figure 68. India G-CSF Injection Revenue (2018-2029) & (US$ Million)
  • Figure 69. Middle East, Africa and Latin America G-CSF Injection Sales Market Share by Type (2018-2029)
  • Figure 70. Middle East, Africa and Latin America G-CSF Injection Revenue Market Share by Type (2018-2029)
  • Figure 71. Middle East, Africa and Latin America G-CSF Injection Sales Market Share by Application (2018-2029)
  • Figure 72. Middle East, Africa and Latin America G-CSF Injection Revenue Market Share by Application (2018-2029)
  • Figure 73. Middle East, Africa and Latin America G-CSF Injection Revenue Share by Country (2018-2029)
  • Figure 74. Middle East, Africa and Latin America G-CSF Injection Sales Share by Country (2018-2029)
  • Figure 75. Brazil G-CSF Injection Revenue (2018-2029) & (US$ Million)
  • Figure 76. Mexico G-CSF Injection Revenue (2018-2029) & (US$ Million)
  • Figure 77. Turkey G-CSF Injection Revenue (2018-2029) & (US$ Million)
  • Figure 78. Israel G-CSF Injection Revenue (2018-2029) & (US$ Million)
  • Figure 79. GCC Countries G-CSF Injection Revenue (2018-2029) & (US$ Million)
  • Figure 80. G-CSF Injection Value Chain
  • Figure 81. G-CSF Injection Production Process
  • Figure 82. Channels of Distribution
  • Figure 83. Distributors Profiles
  • Figure 84. Bottom-up and Top-down Approaches for This Report
  • Figure 85. Data Triangulation
  • Figure 86. Key Executives Interviewed
目次

This research report focuses on the G-CSF Injection Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 G-CSF Injection Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global G-CSF Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Long-acting G-CSF Injection
    • 1.2.3 Short-acting G-CSF Injection
  • 1.3 Market by Application
    • 1.3.1 Global G-CSF Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Neoplastic Diseases
    • 1.3.3 Blood Disorders
    • 1.3.4 Others
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Executive Summary

  • 2.1 Global G-CSF Injection Sales Estimates and Forecasts 2018-2029
  • 2.2 Global G-CSF Injection Revenue by Region
    • 2.2.1 Global G-CSF Injection Revenue by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Global G-CSF Injection Revenue by Region (2018-2023)
    • 2.2.3 Global G-CSF Injection Revenue by Region (2024-2029)
    • 2.2.4 Global G-CSF Injection Revenue Market Share by Region (2018-2029)
  • 2.3 Global G-CSF Injection Sales Estimates and Forecasts 2018-2029
  • 2.4 Global G-CSF Injection Sales by Region
    • 2.4.1 Global G-CSF Injection Sales by Region: 2018 VS 2022 VS 2029
    • 2.4.2 Global G-CSF Injection Sales by Region (2018-2023)
    • 2.4.3 Global G-CSF Injection Sales by Region (2024-2029)
    • 2.4.4 Global G-CSF Injection Sales Market Share by Region (2018-2029)
  • 2.5 US & Canada
  • 2.6 Europe
  • 2.7 China
  • 2.8 Asia (excluding China)
  • 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

  • 3.1 Global G-CSF Injection Sales by Manufacturers
    • 3.1.1 Global G-CSF Injection Sales by Manufacturers (2018-2023)
    • 3.1.2 Global G-CSF Injection Sales Market Share by Manufacturers (2018-2023)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of G-CSF Injection in 2022
  • 3.2 Global G-CSF Injection Revenue by Manufacturers
    • 3.2.1 Global G-CSF Injection Revenue by Manufacturers (2018-2023)
    • 3.2.2 Global G-CSF Injection Revenue Market Share by Manufacturers (2018-2023)
    • 3.2.3 Global Top 10 and Top 5 Companies by G-CSF Injection Revenue in 2022
  • 3.3 Global Key Players of G-CSF Injection, Industry Ranking, 2021 VS 2022 VS 2023
  • 3.4 Global G-CSF Injection Sales Price by Manufacturers
  • 3.5 Analysis of Competitive Landscape
    • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.5.2 Global G-CSF Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.6 Global Key Manufacturers of G-CSF Injection, Manufacturing Base Distribution and Headquarters
  • 3.7 Global Key Manufacturers of G-CSF Injection, Product Offered and Application
  • 3.8 Global Key Manufacturers of G-CSF Injection, Date of Enter into This Industry
  • 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global G-CSF Injection Sales by Type
    • 4.1.1 Global G-CSF Injection Historical Sales by Type (2018-2023)
    • 4.1.2 Global G-CSF Injection Forecasted Sales by Type (2024-2029)
    • 4.1.3 Global G-CSF Injection Sales Market Share by Type (2018-2029)
  • 4.2 Global G-CSF Injection Revenue by Type
    • 4.2.1 Global G-CSF Injection Historical Revenue by Type (2018-2023)
    • 4.2.2 Global G-CSF Injection Forecasted Revenue by Type (2024-2029)
    • 4.2.3 Global G-CSF Injection Revenue Market Share by Type (2018-2029)
  • 4.3 Global G-CSF Injection Price by Type
    • 4.3.1 Global G-CSF Injection Price by Type (2018-2023)
    • 4.3.2 Global G-CSF Injection Price Forecast by Type (2024-2029)

5 Market Size by Application

  • 5.1 Global G-CSF Injection Sales by Application
    • 5.1.1 Global G-CSF Injection Historical Sales by Application (2018-2023)
    • 5.1.2 Global G-CSF Injection Forecasted Sales by Application (2024-2029)
    • 5.1.3 Global G-CSF Injection Sales Market Share by Application (2018-2029)
  • 5.2 Global G-CSF Injection Revenue by Application
    • 5.2.1 Global G-CSF Injection Historical Revenue by Application (2018-2023)
    • 5.2.2 Global G-CSF Injection Forecasted Revenue by Application (2024-2029)
    • 5.2.3 Global G-CSF Injection Revenue Market Share by Application (2018-2029)
  • 5.3 Global G-CSF Injection Price by Application
    • 5.3.1 Global G-CSF Injection Price by Application (2018-2023)
    • 5.3.2 Global G-CSF Injection Price Forecast by Application (2024-2029)

6 US & Canada

  • 6.1 US & Canada G-CSF Injection Market Size by Type
    • 6.1.1 US & Canada G-CSF Injection Sales by Type (2018-2029)
    • 6.1.2 US & Canada G-CSF Injection Revenue by Type (2018-2029)
  • 6.2 US & Canada G-CSF Injection Market Size by Application
    • 6.2.1 US & Canada G-CSF Injection Sales by Application (2018-2029)
    • 6.2.2 US & Canada G-CSF Injection Revenue by Application (2018-2029)
  • 6.3 US & Canada G-CSF Injection Market Size by Country
    • 6.3.1 US & Canada G-CSF Injection Revenue by Country: 2018 VS 2022 VS 2029
    • 6.3.2 US & Canada G-CSF Injection Sales by Country (2018-2029)
    • 6.3.3 US & Canada G-CSF Injection Revenue by Country (2018-2029)
    • 6.3.4 US
    • 6.3.5 Canada

7 Europe

  • 7.1 Europe G-CSF Injection Market Size by Type
    • 7.1.1 Europe G-CSF Injection Sales by Type (2018-2029)
    • 7.1.2 Europe G-CSF Injection Revenue by Type (2018-2029)
  • 7.2 Europe G-CSF Injection Market Size by Application
    • 7.2.1 Europe G-CSF Injection Sales by Application (2018-2029)
    • 7.2.2 Europe G-CSF Injection Revenue by Application (2018-2029)
  • 7.3 Europe G-CSF Injection Market Size by Country
    • 7.3.1 Europe G-CSF Injection Revenue by Country: 2018 VS 2022 VS 2029
    • 7.3.2 Europe G-CSF Injection Sales by Country (2018-2029)
    • 7.3.3 Europe G-CSF Injection Revenue by Country (2018-2029)
    • 7.3.4 Germany
    • 7.3.5 France
    • 7.3.6 U.K.
    • 7.3.7 Italy
    • 7.3.8 Russia

8 China

  • 8.1 China G-CSF Injection Market Size
    • 8.1.1 China G-CSF Injection Sales (2018-2029)
    • 8.1.2 China G-CSF Injection Revenue (2018-2029)
  • 8.2 China G-CSF Injection Market Size by Application
    • 8.2.1 China G-CSF Injection Sales by Application (2018-2029)
    • 8.2.2 China G-CSF Injection Revenue by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia G-CSF Injection Market Size by Type
    • 9.1.1 Asia G-CSF Injection Sales by Type (2018-2029)
    • 9.1.2 Asia G-CSF Injection Revenue by Type (2018-2029)
  • 9.2 Asia G-CSF Injection Market Size by Application
    • 9.2.1 Asia G-CSF Injection Sales by Application (2018-2029)
    • 9.2.2 Asia G-CSF Injection Revenue by Application (2018-2029)
  • 9.3 Asia G-CSF Injection Sales by Region
    • 9.3.1 Asia G-CSF Injection Revenue by Region: 2018 VS 2022 VS 2029
    • 9.3.2 Asia G-CSF Injection Revenue by Region (2018-2029)
    • 9.3.3 Asia G-CSF Injection Sales by Region (2018-2029)
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 China Taiwan
    • 9.3.7 Southeast Asia
    • 9.3.8 India

10 Middle East, Africa and Latin America

  • 10.1 Middle East, Africa and Latin America G-CSF Injection Market Size by Type
    • 10.1.1 Middle East, Africa and Latin America G-CSF Injection Sales by Type (2018-2029)
    • 10.1.2 Middle East, Africa and Latin America G-CSF Injection Revenue by Type (2018-2029)
  • 10.2 Middle East, Africa and Latin America G-CSF Injection Market Size by Application
    • 10.2.1 Middle East, Africa and Latin America G-CSF Injection Sales by Application (2018-2029)
    • 10.2.2 Middle East, Africa and Latin America G-CSF Injection Revenue by Application (2018-2029)
  • 10.3 Middle East, Africa and Latin America G-CSF Injection Sales by Country
    • 10.3.1 Middle East, Africa and Latin America G-CSF Injection Revenue by Country: 2018 VS 2022 VS 2029
    • 10.3.2 Middle East, Africa and Latin America G-CSF Injection Revenue by Country (2018-2029)
    • 10.3.3 Middle East, Africa and Latin America G-CSF Injection Sales by Country (2018-2029)
    • 10.3.4 Brazil
    • 10.3.5 Mexico
    • 10.3.6 Turkey
    • 10.3.7 Israel
    • 10.3.8 GCC Countries

11 Company Profiles

  • 11.1 Amgen Inc.
    • 11.1.1 Amgen Inc. Company Information
    • 11.1.2 Amgen Inc. Overview
    • 11.1.3 Amgen Inc. G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.1.4 Amgen Inc. G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Amgen Inc. Recent Developments
  • 11.2 Pfizer
    • 11.2.1 Pfizer Company Information
    • 11.2.2 Pfizer Overview
    • 11.2.3 Pfizer G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.2.4 Pfizer G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Pfizer Recent Developments
  • 11.3 Sandoz (Novartis)
    • 11.3.1 Sandoz (Novartis) Company Information
    • 11.3.2 Sandoz (Novartis) Overview
    • 11.3.3 Sandoz (Novartis) G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.3.4 Sandoz (Novartis) G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Sandoz (Novartis) Recent Developments
  • 11.4 Spectrum Pharmaceuticals
    • 11.4.1 Spectrum Pharmaceuticals Company Information
    • 11.4.2 Spectrum Pharmaceuticals Overview
    • 11.4.3 Spectrum Pharmaceuticals G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.4.4 Spectrum Pharmaceuticals G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Spectrum Pharmaceuticals Recent Developments
  • 11.5 Biocon Biologics Inc.
    • 11.5.1 Biocon Biologics Inc. Company Information
    • 11.5.2 Biocon Biologics Inc. Overview
    • 11.5.3 Biocon Biologics Inc. G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.5.4 Biocon Biologics Inc. G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Biocon Biologics Inc. Recent Developments
  • 11.6 Coherus BioSciences, Inc.
    • 11.6.1 Coherus BioSciences, Inc. Company Information
    • 11.6.2 Coherus BioSciences, Inc. Overview
    • 11.6.3 Coherus BioSciences, Inc. G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.6.4 Coherus BioSciences, Inc. G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Coherus BioSciences, Inc. Recent Developments
  • 11.7 Teva Pharmaceutical
    • 11.7.1 Teva Pharmaceutical Company Information
    • 11.7.2 Teva Pharmaceutical Overview
    • 11.7.3 Teva Pharmaceutical G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.7.4 Teva Pharmaceutical G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Teva Pharmaceutical Recent Developments
  • 11.8 Sanofi
    • 11.8.1 Sanofi Company Information
    • 11.8.2 Sanofi Overview
    • 11.8.3 Sanofi G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.8.4 Sanofi G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 Sanofi Recent Developments
  • 11.9 Yifan Pharmaceutical
    • 11.9.1 Yifan Pharmaceutical Company Information
    • 11.9.2 Yifan Pharmaceutical Overview
    • 11.9.3 Yifan Pharmaceutical G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.9.4 Yifan Pharmaceutical G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 Yifan Pharmaceutical Recent Developments
  • 11.10 CSPC
    • 11.10.1 CSPC Company Information
    • 11.10.2 CSPC Overview
    • 11.10.3 CSPC G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.10.4 CSPC G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.10.5 CSPC Recent Developments
  • 11.11 Jiangsu Hengrui Medicine
    • 11.11.1 Jiangsu Hengrui Medicine Company Information
    • 11.11.2 Jiangsu Hengrui Medicine Overview
    • 11.11.3 Jiangsu Hengrui Medicine G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.11.4 Jiangsu Hengrui Medicine G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.11.5 Jiangsu Hengrui Medicine Recent Developments
  • 11.12 Qilu Pharmaceutical
    • 11.12.1 Qilu Pharmaceutical Company Information
    • 11.12.2 Qilu Pharmaceutical Overview
    • 11.12.3 Qilu Pharmaceutical G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.12.4 Qilu Pharmaceutical G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.12.5 Qilu Pharmaceutical Recent Developments
  • 11.13 Shan Dong Kexing Biopharm
    • 11.13.1 Shan Dong Kexing Biopharm Company Information
    • 11.13.2 Shan Dong Kexing Biopharm Overview
    • 11.13.3 Shan Dong Kexing Biopharm G-CSF Injection Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.13.4 Shan Dong Kexing Biopharm G-CSF Injection Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.13.5 Shan Dong Kexing Biopharm Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 G-CSF Injection Industry Chain Analysis
  • 12.2 G-CSF Injection Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 G-CSF Injection Production Mode & Process
  • 12.4 G-CSF Injection Sales and Marketing
    • 12.4.1 G-CSF Injection Sales Channels
    • 12.4.2 G-CSF Injection Distributors
  • 12.5 G-CSF Injection Customers

13 Market Dynamics

  • 13.1 G-CSF Injection Industry Trends
  • 13.2 G-CSF Injection Market Drivers
  • 13.3 G-CSF Injection Market Challenges
  • 13.4 G-CSF Injection Market Restraints

14 Key Findings in The Global G-CSF Injection Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer